AngioDynamics, Inc. (ANGO) Operating cash flow 2017–2026
AngioDynamics, Inc. (ANGO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$3.1MFY2026 · since FY2017: $55.7M → $3.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $3.1M | +130.5% |
| FY2025 | -$10.1M | +64.0% |
| FY2024 | -$28.2M | -36200.0% |
| FY2023 | $78,000 | +101.1% |
| FY2022 | -$7.2M | -129.9% |
| FY2021 | $24.1M | +265.5% |
| FY2020 | -$14.6M | -138.9% |
| FY2019 | $37.4M | -9.3% |
| FY2018 | $41.3M | -25.9% |
| FY2017 | $55.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANGO financial trends
ANGO RevenueANGO Net incomeANGO Net marginANGO Gross profitANGO Gross marginANGO Operating incomeANGO Operating marginANGO Free cash flowANGO Capital expendituresANGO Return on equityANGO Stock buybacksANGO Dividends paidANGO Total assetsANGO Total liabilitiesANGO Shareholders’ equityANGO overview →